Intravenous immunoglobulins in pediatrics: immediate and delayed adverse events
Intravenous administration of immunoglobulins in pediatrics is used for an increasing number of indications. First of all, primary and secondary immunodeficiencies, but also and more and more frequently, inflammatory and autoimmune diseases such as Kawasaki disease, idiopathic thrombocytopenic purpura, Guillain-Barrè syndrome, autoimmune encephalopathies, myasthenia, polymyositis and epilepsy.